About Index Trending news
Analyze
Pricing
Epic Sciences

Epic Sciences

Work at Epic Sciences? Add yourself to this profile

Epic Sciences

Developing new diagnostic blood tests that can identify and characterize circulating tumor cells to improve cancer detection and to personalize medicine.
Edit Profile
More info

Elsewhere

Contributors to this profile

Companies in the same industry

Idenix Pharmaceuticals Idenix Pharmaceuticals Linkage Biosciences Linkage Biosciences Synlogic Therapeutics Synlogic Therapeutics Niti Surgical Solutions Niti Surgical Solutions Puridify Puridify RedHill Biopharma RedHill Biopharma Synta Pharmaceuticals Synta Pharmaceuticals Rockwell Medical Rockwell Medical Neos Therapeutics, Inc. Neos Therapeutics, Inc. Ridge Diagnostics Ridge Diagnostics

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
Latest funding Show all
Venture capital (Series D)
$40,000,000
Domain Associates, Genomic Health, Sabby Capital, +6
Debt financing
$15,000,000
Silicon Valley Bank
Employees

Unknown size

Locations
HQ
United States
Headquarters
Xconomy

Epic Sciences Advances Diagnostic for Late-Stage Prostate Cancer

Health Science Funding
Epic Sciences
Epic Sciences
$40,000,000 Venture capital (Series D)
PE Hub

Epic Sciences takes in $40 mln Series D

Funding Messaging
Epic Sciences
Epic Sciences